Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away.
That’s the vision of the field of bioelectronic medicine — the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News(C&EN), the weekly news magazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.
Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.
The Latest on: Bioelectronics
[google_news title=”” keyword=”Bioelectronics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioelectronics
- Black Rock Coffee Bar to Open its Sixth Store in Austin, Texason July 25, 2024 at 2:29 pm
Black Rock Coffee Bar, known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks, is bringing its unique coffee ...
- Nanotech And Bioelectronics: We Have To Pay Attention To This!on July 25, 2024 at 7:08 am
Even, she says, cells that are not electronically excitable can respond to nanotech bioelectronics. She also mentions “autonomous” therapies. “We will not remain slaves to disease,” she says, also ...
- Analog Devices, Flagship team up to create digital biology startupson July 24, 2024 at 5:00 pm
Flagship Pioneering is teaming up with a Wilmington-based semiconductor company to build startups. Flagship Pioneering is teaming up with semiconductor giant Analog Devices to build startups with the ...
- Novel biosensor could enable fast, precise disease diagnosis and preventionon July 24, 2024 at 10:19 am
A research team affiliated with UNIST has unveiled biosensor technology that uses light to quickly and accurately detect trace amounts of proteins. This breakthrough has significant implications for ...
- NIKE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS ...on July 23, 2024 at 7:50 pm
NEW ORLEANS, July 23, 2024 (GLOBE NEWSWIRE) -- (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they ...
- Slimy new invention is breakthrough for bioelectronics and soft roboticson July 19, 2024 at 7:09 pm
Made from hydrogels — networks of polymers that are more than 60 per cent water — the self-healing batteries can stretch to more than 10 times their original length without affecting conductivity. It ...
- Galvani Bioelectronics Announces Clinical Progression of Its Therapy Platform and Addition of New Chief Medical Officeron July 17, 2024 at 1:19 pm
Galvani Bioelectronics, a clinical-stage therapeutics company formed through a strategic partnership between GSK and Verily Life Sciences to develop targeted neuromodulation therapies, today announced ...
- Researchers develop 'jelly-like' batteries to power wearable devices, brain implantson July 17, 2024 at 11:00 am
Cambridge University said its researchers have developed an electric-eel-inspired, jelly-like, battery for use in wearable devices and potentially for brain implants to treat neurological conditions.
- Soft, stretchy ‘jelly batteries’ inspired by electric eelson July 17, 2024 at 11:00 am
Researchers have developed soft, stretchable ‘jelly batteries’ that could be used for wearable devices or soft robotics, or even implanted in the brain to deliver drugs or treat conditions such as ...
- ShiraTronics’ neuromodulation device reduces migraine frequencyon July 16, 2024 at 11:32 pm
There are several neuromodulation devices on the market to treat migraine. Theranica Bioelectronics’s smartphone-controlled wearable neuromodulation device, Nerivio, was granted de novo approval by ...
via Bing News
